2025 International Cancer Immunotherapy Conference (CICON25)

The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI) are proud to present the Ninth International Cancer lmmunotherapy Conference, CICON25, taking place September 10-12, 2025, in Utrecht, The Netherlands.

The CICON meeting series was launched in 2015 as a transnational forum for basic and translational research in cancer immunology and immunotherapy.

Presented by the Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI), and alternating between the United States and Europe, CICON is organized by the leaders of this fast-moving field, gathering more than 1,000 cancer immunology and immunotherapy specialists from all over the world.

Conference Co-Chairs

Özlem Türeci, Mainz, Germany
Cornelis M. Melief, Leiden, The Netherlands
Nina Bhardwaj, New York, USA

CICON25 Scientific Program Committee

Sergio Abrignani, National Institute of Molecular Genetics (INGM), Italy
Valsamo Anagnostou, Johns Hopkins Medicine, USA
Ana Arance, Hospital Clinic Barcelona, Spain
Marcel van den Brink, City of Hope, USA
Vincenzo Bronte, Istituto Oncologico Veneto IRCCS, Italy
Lorenzo Galluzzi, Fox Chase Cancer Center, USA
Manel Juan, Hospital Clinic Barcelona, Spain
Christina Leslie, Memorial Sloan Kettering Cancer Center, USA
Yifat Merbl, Weizmann Insitute of Science, Israel
Catherine Sautes-Fridman, Cordeliers Research Center, France
Matthew Spitzer, UC San Francisco, USA
Cassian Yee, MD Anderson Cancer Center, USA

Learn More:

Register